SLC5A2 and type 2 diabetes mellitus: Very few meta-analyses or systematic reviews have investigated the effects of SGLT2 inhibitors on the risk of stroke in patients with T2DM, therefore a meta-analysis of all relevant published literature from RCTs was performed to qualitatively and quantitatively investigate the effects of SGLT2 inhibitors on the risk of stroke in diabetic individuals.